A telehealth-based smoking cessation program significantly improved quit rates among patients with cancer treated at community practices.
A randomized trial showed patients who received the virtual intervention, which also included no-cost medication, achieved double the abstinence rate at 6 months compared with those who were referred to the NCI quitline.
“Helping patients stop smoking after a cancer diagnosis is feasible and impactful, and it can be readily embedded into community oncology care,” Jamie S. Ostroff, PhD, chief of behavioral sciences service and director of the tobacco treatment